Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 22

    1.

    Diagnosis of diabetic peripheral neuropathy among patients with type 1 and type 2 diabetes in France, Italy, Spain, and the United Kingdom.

    Rubino A, Rousculp MD, Davis K, Wang J, Bastyr EJ, Tesfaye S.

    Prim Care Diabetes. 2007 Sep;1(3):129-34. Epub 2007 Aug 17.PMID: 18632033 [PubMed - indexed for MEDLINE]Related articles

    2.

    Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.

    Tesfaye S, Tandan R, Bastyr EJ 3rd, Kles KA, Skljarevski V, Price KL; Ruboxistaurin Study Group.

    Diabetes Care. 2007 Oct;30(10):2626-32. Epub 2007 Jul 10.PMID: 17623822 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity.

    Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, Bastyr EJ 3rd, Litchy WJ, O'Brien PC.

    Diabetes Care. 2007 Oct;30(10):2619-25. Epub 2007 May 18.PMID: 17513707 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.

    Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr EJ 3rd, Wolka AM, Vinik AI.

    Diabetes Care. 2007 Apr;30(4):896-902.PMID: 17392551 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Clinical safety of the selective PKC-beta inhibitor, ruboxistaurin.

    McGill JB, King GL, Berg PH, Price KL, Kles KA, Bastyr EJ, Hyslop DL.

    Expert Opin Drug Saf. 2006 Nov;5(6):835-45. Review.PMID: 17044810 [PubMed - indexed for MEDLINE]Related articles

    6.

    Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.

    Bastyr EJ 3rd, Price KL, Bril V; MBBQ Study Group.

    Clin Ther. 2005 Aug;27(8):1278-94.PMID: 16199253 [PubMed - indexed for MEDLINE]Related articles

    7.

    Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.

    Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

    Clin Ther. 2005 Aug;27(8):1164-80.PMID: 16199243 [PubMed - indexed for MEDLINE]Related articles

    8.

    Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy.

    Vinik AI, Bril V, Litchy WJ, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

    Muscle Nerve. 2005 Nov;32(5):619-25.PMID: 16116628 [PubMed - indexed for MEDLINE]Related articles

    9.

    Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro.

    Bastyr EJ 3rd, Huang Y, Brunelle RL, Vignati L, Cox DJ, Kotsanos JG.

    Diabetes Obes Metab. 2000 Jan;2(1):39-46.PMID: 11220353 [PubMed - indexed for MEDLINE]Related articles

    10.

    Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

    Bastyr EJ 3rd, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE.

    Diabetes Care. 2000 Sep;23(9):1236-41.PMID: 10977012 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.

    Bastyr EJ 3rd, Johnson ME, Trautmann ME, Anderson JH Jr, Vignati L.

    Clin Ther. 1999 Oct;21(10):1703-14.PMID: 10566566 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic and immunologic effects of insulin lispro in gestational diabetes.

    Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, Bastyr EJ 3rd.

    Diabetes Care. 1999 Sep;22(9):1422-7.PMID: 10480503 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Safety of insulin lispro: pooled data from clinical trials.

    Glazer NB, Zalani S, Anderson JH Jr, Bastyr EJ 3rd.

    Am J Health Syst Pharm. 1999 Mar 15;56(6):542-7.PMID: 10192689 [PubMed - indexed for MEDLINE]Related articles

    14.

    Poor glycaemic control and retinopathy in non-insulin-dependent diabetes mellitus.

    Bastyr EJ 3rd, Janes J, Barnett AH.

    Diabet Med. 1997 Nov;14(11):993-4. No abstract available. PMID: 9400930 [PubMed - indexed for MEDLINE]Related articles

    15.

    Mixing insulin lispro and ultralente insulin.

    Bastyr EJ 3rd, Holcombe JH, Anderson JH, Clore JN.

    Diabetes Care. 1997 Jun;20(6):1047-8. No abstract available. PMID: 9167130 [PubMed - indexed for MEDLINE]Related articles

    16.

    Latex allergen allergic reactions.

    Bastyr EJ 3rd.

    Diabetes Care. 1996 May;19(5):546. No abstract available. PMID: 8732725 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise.

    Raguso CA, Coggan AR, Gastaldelli A, Sidossis LS, Bastyr EJ 3rd, Wolfe RR.

    Diabetes. 1995 Sep;44(9):1066-74.PMID: 7657030 [PubMed - indexed for MEDLINE]Related articles

    18.

    Low molecular weight GTP-binding proteins are altered in platelet hyperaggregation in IDDM.

    Bastyr EJ 3rd, Lu J, Stowe R, Green A, Vinik AI.

    Oncogene. 1993 Feb;8(2):515-8.PMID: 8426753 [PubMed - indexed for MEDLINE]Related articles

    19.

    Reduced guanine nucleotide-stimulated polyphosphoinositide specific phospholipase C in platelet hyperaggregation in IDDM.

    Bastyr EJ 3rd, Vinik AI.

    Thromb Res. 1992 Jan 15;65(2):241-52.PMID: 1315991 [PubMed - indexed for MEDLINE]Related articles

    20.

    Platelet activity and phosphoinositide turnover increase with advancing age.

    Bastyr EJ 3rd, Kadrofske MM, Vinik AI.

    Am J Med. 1990 Jun;88(6):601-6.PMID: 2161185 [PubMed - indexed for MEDLINE]Related articles

    21.

    Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus.

    Gonin JM, Kadrofske MM, Schmaltz S, Bastyr EJ 3rd, Vinik AI.

    Diabetes Care. 1990 Jan;13(1):68-71.PMID: 2298113 [PubMed - indexed for MEDLINE]Related articles

    22.

    Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM.

    Bastyr EJ 3rd, Kadrofske MM, Dershimer RC, Vinik AI.

    Diabetes. 1989 Sep;38(9):1097-102.PMID: 2548908 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...